Drawing for RAQUALIA INNOVATIONS

USPTO serial 88783131

RAQUALIA INNOVATIONS

Reviewed by CopyMark Law Group

Reg. 6292142Status 700Renewal
Filing date
Status date
Registration date
Mar 16, 2021
Examiner
ERVIN, INGA
Law office
PUBLICATION AND ISSUE SECTION

What this means

This registration is in, or will soon enter, a USPTO maintenance window. Missing a Section 8 or Section 9 filing can cancel the registration.

Status 700: Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six.

Need help with RAQUALIA INNOVATIONS?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Get help with this Renewal, set up monitoring, or talk with CopyMark.
Get Attorney Assistance for just $1,795*

Plus Government fees of $1,625

Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Patchen M. Haggerty

Patchen M. Haggerty PERKINS COIE LLP1201 THIRD AVENUE, SUITE 4900SEATTLE, WA 98101UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
005Pharmaceutical preparations for the treatment of pain, GI (gastrointestinal disease), cancer, CNS disorder (central nervous system disorder), infectious diseases, metabolic diseases, cardiovascular diseases, dermatological diseases, eye diseases, liver diseases, musculo-skeletal disorders, immune system related diseases and disorders, respiratory diseases, psychiatric diseases and disorders, damaged skin and tissue, diabetes, hypertension, blood disorders, inflammation, viral diseases, endocrine disorders, genitourinary disorders, sexual dysfunction, oncological disorders, hepatological disorders, kidney diseases, ophthalmic disorders, otolaryngologic diseases, neurological disorders, hormonal disorders, inflammatory disorders, chemical imbalances, sepsis, arthritis, allergies, alopecia, obesity and cognitive disordersACTIVE—
035Business management consultancy and providing information thereof; business consultancy; mediation of trade businesses for third parties; and business intermediary services relating to the matching of potential private investors with entrepreneurs needing funding; business merger consultation; business advisory services, consultancy and information; business management; operational business assistance to enterprises; negotiation of business contracts for others and consultancy, advisory and information services thereof; commercial management; promoting the sale of goods and services of others; business research and business appraisal consultation; business management analysis and business consultancy; marketing research or analysis; provision of information concerning commercial salesACTIVE—
036Investment of funds; investment consultancy; investment brokerage and investment management services; providing investment information; providing financial information; financial asset management services and consultancy, advisory and information services thereof; financial risk assessment; evaluation of the credit worthiness of companies and private individuals; securities brokerage; trading of securities index futures; trading of securities options; trading of overseas market securities futures; agencies or brokerage for trading of securities; trading of securities index futures; trading of securities options and overseas market securities futures; agencies for brokerage of entrusting agents with on-commission trading in domestic markets of securities, securities index futures and securities options; agencies for brokerage of entrusting agents with on-commission trading in overseas markets of securities and overseas market securities futures; agencies for brokerage of forward agreement of securities, for forward agreement of securities index futures, for forward agreement of securities options and spot and forward transaction of securities index futures; brokerage for securities liquidation; securities underwriting; fund investment services featuring securities offered according to previously established criteria in order to maintain a predetermined level of payments for the account holder; brokerage services relating to securities subscription or offering; providing stock market information; securities deposit services; brokerage services for stocks and bonds; acceptance of deposits including substitute bond issuance and acceptance of fixed interval installment deposits; loan financing and discount of bills; domestic exchange debt settlement; liability guarantee and acceptance of bills; securities lending; acquisition and transfer of monetary claims; temporary safekeeping of valuables including securities and precious metals as safe deposit box services; money exchange services; trusteeship representatives of financial futures contracts; trusteeship representatives of money, securities, monetary claims, personal property, land, rights on land fixtures, surface rights or lease on land; agencies for bond subscriptions; foreign exchange transactions; issuing of letter-of-credit related services; promoting the sale of goods and services of others by awarding purchase points for credit card use; real estate lending services; leasing of real estate; real estate management; real estate agency services; rental of buildings for permanent occupancy; agencies or brokerage for renting of land; real estate agency services relating to the purchase or sale of land and buildings; real estate appraisalACTIVE—
042Testing of medicines; testing of pharmaceuticals; testing of chemicals; testing of cosmetics; research and development of pharmaceutical preparations and medicine; research and development of cosmetics; chemical research; scientific research consulting in the field of medicine; scientific research consulting in the field of pharmaceuticals; scientific research consulting in the field of chemicals; scientific research consulting in the field of cosmetics; providing medical and scientific research information in the field of pharmaceuticals and medicines; providing scientific research information in the field of cosmeticsACTIVE—
045Licensing of intellectual property; legal services, namely, brokerage and mediation of contracts for the purchase and sale of intellectual property rights; advisory services relating to intellectual property rights; intellectual property consultation services featuring commercialization of intellectual property; providing information about intellectual property rightsACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Mar 16, 2026REM1COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED—
Mar 16, 2021R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Dec 29, 2020NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Dec 29, 2020PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Dec 9, 2020NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Nov 24, 2020FIXDELECTRONIC RECORD REVIEW COMPLETE—
Nov 20, 2020ERRRON HOLD - ELECTRONIC RECORD REVIEW REQUIRED—
Nov 18, 2020CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Oct 29, 2020TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Oct 28, 2020CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Oct 28, 2020TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
May 5, 2020GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
May 5, 2020GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
May 5, 2020CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Apr 22, 2020DOCKASSIGNED TO EXAMINER—
Feb 6, 2020NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Feb 6, 2020NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance